Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study

Yue Fei,1 Zhihong Xie,2 Yuanyuan Luo,3 Xiaolan Yong,4 Na Li,1 Rong Huang,1 Xiaolin Du,4 Yijing Zhu,4 Dongmei Lan,3 Yang Qi,3 Gang Cheng,1 Quanren Wang,1 Kai Shen1 1Department of Clinical Research, Jiangsu Hengrui Pharmaceuticals, Shanghai, People’s Republic of China; 2Phase I Clinical Trial Center,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Fei Y, Xie Z, Luo Y, Yong X, Li N, Huang R, Du X, Zhu Y, Lan D, Qi Y, Cheng G, Wang Q, Shen K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2025-05-01
coleção:	Drug Design, Development and Therapy
Assuntos:	mineralocorticoid receptor antagonist pharmacokinetics renal impairment chronic kidney disease
Acesso em linha:	https://www.dovepress.com/pharmacokinetics-and-safety-of-hrs-1780-in-renal-impaired-subjects-a-m-peer-reviewed-fulltext-article-DDDT
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!